|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| C07K 16/10 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/32 | (2006.01) |
| (11) | Number of the document | 4249515 |
| (13) | Kind of document | T |
| (96) | European patent application number | 23174159.6 |
| Date of filing the European patent application | 2015-01-08 | |
| (97) | Date of publication of the European application | 2023-09-27 |
| (45) | Date of publication and mention of the grant of the patent | 2025-06-18 |
| (46) | Date of publication of the claims translation | 2025-08-25 |
| (30) | Number | Date | Country code |
| PA201400009 | 2014-01-09 | DK | |
| PCT/EP2014/050340 | 2014-01-09 | WO | |
| PCT/EP2014/064326 | 2014-07-04 | WO |
| (72) |
BRINK, Edward Norbert Van Den , NL
NEIJSSEN, Joost J. , NL
LABRIJN, Aran Frank , NL
MEESTERS, Joyce , NL
SCHUURMAN, Janine , NL
ALTINTAS, Isil , NL
PARREN, Paul , NL
RADEMAKER, Rik , NL
|
| (73) |
Genmab A/S ,
Carl Jacobsens Vej 30, 2500 Valby,
DK
|
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Humanizuoti arba chimeriniai CD3 antikūnai |
| HUMANIZED OR CHIMERIC CD3 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-12-04 | 12 | 289.00 EUR |
| 2027-01-08 |